| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |